Directors' Talk DPHARM 2025 - Keynotes & Key Topics; Part I
In this podcast series, DPHARM Directors Valerie Bowling and Tracey Kimball break down what to expect at DPHARM 2025. Part I of this podcast series covers keynotes and key topics for this year's event, including:Former Merck CEO, Ken FrazierFormer Head of FDA, Scott GottliebCRISPR Gene Therapy Patient Keynote, Victoria GrayTuft's Ken GetzHow DPHARM is tackling AIWhat to do about Protocol Complexityand moreWant to know more about DPHARM? Check it out at DPHARMconference.com.
--------
12:09
Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
About this podcast: Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community connections and protocol feedback. Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Trish Davidson, Senior Consultant at the Tufts Center for the Study of Drug Development and Director, PALADIN Consortium about the role of patient advocacy groups in medicine development and how PALADIN is connecting industry stakeholders to reduce duplicative efforts in patient engagement resources and advance more efficient patient engagement across the industry.In the podcast, Matt touches upon IQVIA's recent collection of perspectives from researchers, approvers and patients. The book, Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet? was collated and edited by Matt and gathers diverse insights on patient-centric intervention development. In formats ranging from poetry to short fiction and personal narratives to more traditional reviews of the research, 30+ contributors across the industry discuss how to be truly “patient centric.” It can be accessed for free at https://bit.ly/PatientCentricityBook. For more information on PharmaTalk Radio podcasts, you can visit theconferenceforum.org.
--------
24:37
Lessons Learned in the Development and Introduction of Closed Loop Systems
This podcast features a panel discussion from the 2024 PODD Conference with pharma, medtech and academic leaders about technological development and patient and clinical adoption of closed-loop systems. Specifically:Success in diabetes and lessons for other indications like oncology and CNSNew frontiers in improving closed-loop therapiesIncreasing access across therapy areasTo learn more about the PODD conference, please visit Drug-Delivery.org.
--------
31:52
Best Practices and Potential Pitfalls Enriching Clinical Trials with PROs
Patient-reported outcomes (PROs) are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how to incorporate PROs into clinical trials in ways that improve probabilities of success while avoiding common mistakes. Specifically, the panelists address:How PROs provide evidence on the effect of interventions on patient symptoms and quality of life, but by the nature of being subjective, they are prone to bias The growth of electronic health technologies provides unprecedented opportunities to systematically collect PROsDisadvantages of electronic methods include technical difficulties, cost, longer start-up time, and “digital divide” between patientsTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
--------
32:38
Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
Summary:This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability. The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost. More specifically: Protocol design and executional practice, and the impact of current practices on protocol performanceFramework, process and use cases for optimization of protocol performance through operationalization of patient preferences Direct impact on corporate goals like recruitment, retention and growth For more information, go to DPHARMconference.com
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Netherlands